ProNAi Therapeutics (DNAI) Misses Q2 EPS by 5c

August 12, 2016 7:27 AM EDT
Get Alerts DNAI Hot Sheet
Trade DNAI Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

ProNAi Therapeutics (NASDAQ: DNAI) reported Q2 EPS of ($0.43), $0.05 worse than the analyst estimate of ($0.38).

At June 30, 2016, ProNAi had $130.6 million in cash and cash equivalents compared to $150.2 million in cash and cash equivalents at December 31, 2015.

For earnings history and earnings-related data on ProNAi Therapeutics (DNAI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment